Courier Health Raises $50M Series B for AI Biopharma Patient Experience Platform
Courier Health closed a $50M Series B led by Oak HC/FT for its AI-powered platform designed for biopharma companies, managing the end-to-end patient experience from initial diagnosis through treatment adherence and ongoing support. The platform handles patient journey orchestration — connecting patients, providers, and biopharma manufacturers across the care continuum — at a scale and complexity level where manual coordination traditionally breaks down.
Why It Matters
The round positions Courier Health to expand its AI platform at a time when biopharma companies are under pressure to demonstrate real-world patient outcomes alongside clinical trial efficacy. AI-driven patient journey management addresses a concrete workflow gap in specialty and rare disease treatment, where patient drop-off between prescription and adherence is a measurable problem. Source: Fierce Healthcare.